| Ident. | Authors (with country if any) | Title |
|---|
| 000239 (2012) |
Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Negre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarie [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France] | A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease |
| 000324 (2011) |
Jennifer T. Coull [France] ; Ruey-Kuang Cheng [États-Unis] ; Warren H. Meck [États-Unis] | Neuroanatomical and Neurochemical Substrates of Timing |
| 000339 (2011) |
Imtiaz Ahmed [Royaume-Uni] ; Subrata K. Bose [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Anil Ramlackhansingh [Royaume-Uni] ; Federico Turkheimer [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Alexander Hammers [Royaume-Uni, France] ; David J. Brooks [Royaume-Uni] | Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias |
| 000417 (2010) |
D. Devos [France] ; R. Bordet [France] ; L. Defebvre [France] | Hypothèses pharmacologiques et prise en charge thérapeutique des troubles de la marche de la maladie de Parkinson : Troubles de la marche |
| 000465 (2010) |
Kwamivi Dzahini [France] ; Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Anne Bertrand [France] ; Isabelle Detraz [France] ; Marc Savasta [France] ; Vincent Leviel [France] | Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion |
| 000501 (2010) |
David Devos [France] ; L. Defebvre [France] ; R. Bordet [France] | Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease |
| 000514 (2010) |
Holly M. Brothers [États-Unis] ; Yannick Marchalant [France] ; Gary L. Wenk [États-Unis] | Caffeine attenuates lipopolysaccharide-induced neuroinflammation |
| 000556 (2009) |
A. Eusebio [France] ; J. Micallef-Roll [France] | Glutamate et grandes fonctions cérébrales |
| 000607 (2009) |
Dario Cuomo [France, Italie] ; Giuseppina Martella [Italie] ; Emanuela Barabino [France] ; Paola Platania [Italie] ; Daniela Vita [Italie] ; Graziella Madeo [Italie] ; Chelliah Selvam [France] ; Cyril Goudet [France] ; Nadia Oueslati [France] ; Jean-Philippe Pin [France] ; Francine Acher [France] ; Antonio Pisani [Italie] ; Corinne Beurrier [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France] | Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum : implications for Parkinson's disease treatment |
| 000680 (2008) |
Pierre Cesaro [France] | Neuroprotection et maladie de Parkinson |
| 000723 (2008) |
Imane Nafia [France] ; Diane B. Re [France] ; Frédérique Masmejean [France] ; Christophe Melon [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; André Nieoullon [France] ; Laurence Had-Aissouni [France] | Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction |
| 000736 (2008) |
Luca Ferraro [Italie] ; Maria Cristina Tomasini [Italie] ; Roberta Mazza [Italie] ; Kjell Fuxe [Suède] ; Jacqueline Fournier [France] ; Sergio Tanganelli [Italie] ; Tiziana Antonelli [Italie] | Neurotensin receptors as modulators of glutamatergic transmission |
| 000846 (2007) |
Bradley A. Wallace [France, États-Unis] ; Keyoumars Ashkan [France, Royaume-Uni] ; Claire E. Heise [Australie] ; Kelly D. Foote [États-Unis] ; Napoleon Torres [France] ; John Mitrofanis [France, Australie] ; Alim-Louis Benabid [France] | Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys |
| 000934 (2006) |
G. Mion [France] ; M. Chani [Maroc] ; Y. Diraison [France] | Pharmacologie du récepteur NMDA |
| 000A59 (2005) |
Jean-Philippe Pin [France] | Moduler l'action du glutamate dans le cerveau : De nouvelles pistes ouvertes grâce aux récepteurs métabotropiques |
| 000B24 (2005) |
Nathalie Turle-Lorenzo [France] ; Nathalie Breysse [France] ; Christelle Baunez [France] ; Marianne Amalric [France] | Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease |
| 000B50 (2005) |
Carine Chassain [France] ; Guy Bielicki [France] ; Jean-Pierre Donnat [France] ; Jean-Pierre Renou [France] ; Alain Eschalier [France] ; Franck Durif [France] | Cerebral glutamate metabolism in Parkinson's disease : an in vivo dynamic 13C NMS study in the rat |
| 000D62 (2003) |
Nicolas Bruet [France] ; Francois Windels [France] ; Carole Carcenac [France] ; Claude Feuerstein [France] ; Anne Bertrand [France] ; Annie Poupard [France] ; Marc Savasta [France] | Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: Increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats |
| 000D71 (2003) |
Mauro Maccarrone [Italie] ; Paolo Gubellini [France, Italie] ; Monica Bari [Italie] ; Barbara Picconi [Italie] ; Natalia Battista [Italie] ; Diego Centonze [Italie] ; Giorgio Bernardi [Italie] ; Alessandro Finazzi-Agro [Italie] ; Paolo Calabresi [Italie] | Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism |
| 000E50 (2002) |
P.-C. Nguimfack Mbodie [France] | La théorie de l'excitotoxicité du glutamate et l'implication potentielle des radicaux libres dans l'étiopathogénie de la schizophrénie apporte-t-elle un éclairage nouveau sur les liens entre : prédisposition génétique, facteurs environnementaux et biologie dans le déterminisme de ce trouble ? |
| 000F44 (2002) |
Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France] | Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice |
